Current and Novel Antiplatelet Therapies for the Treatment of Cardiovascular Diseases

Over the last decades, antiplatelet agents, mainly aspirin and P2Y(12) receptor antagonists, have significantly reduced morbidity and mortality associated with arterial thrombosis. Their pharmacological characteristics, including pharmacokinetic/pharmacodynamics profiles, have been extensively studi...

Descripción completa

Detalles Bibliográficos
Autores principales: Jourdi, Georges, Lordkipanidzé, Marie, Philippe, Aurélien, Bachelot-Loza, Christilla, Gaussem, Pascale
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8658271/
https://www.ncbi.nlm.nih.gov/pubmed/34884884
http://dx.doi.org/10.3390/ijms222313079

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8658271/
https://www.ncbi.nlm.nih.gov/pubmed/34884884
http://dx.doi.org/10.3390/ijms222313079

Ejemplares similares